Therapeutic Advances in Endometriosis-Associated Infertility: From Conventional Hormonal Therapy To Linzagolix

In: Adolescência e Saúde · 2026 · pp. 2945–2956 · doi:10.67440/ahj.vi.2874 · W7224995378
Review OA: hybrid CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-11-20 ⓘ

This review summarizes clinical features, pathogenesis, and therapeutic approaches for endometriosis-associated infertility, contrasting conventional hormonal therapies with the GnRH antagonist linzagolix to address pain and fertility outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-20 · read from full text ⓘ

This review examines the multifactorial nature of endometriosis-associated infertility, detailing pathogenic mechanisms such as pelvic anatomical distortion, ovarian damage, and impaired embryo implantation. It evaluates conventional management strategies including hormonal therapies like ethinyl estradiol and levonorgestrel, alongside surgical interventions and assisted reproductive technologies. The paper also highlights Linzagolix, a GnRH receptor antagonist that suppresses estrogen production to alleviate pain symptoms, noting its potential role in treatment alongside add-back therapy for managing hypoestrogenic effects. This paper is centrally about endometriosis — specifically focusing on therapeutic advances for infertility associated with the condition.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is a chronic estrogen-dependent disorder characterized by endometrial-like tissue outside the uterine cavity and is strongly associated with pelvic pain, inflammation, adhesions, and impaired fertility. Endometriosis-associated infertility is multifactorial and may involve pelvic anatomical distortion, tubal dysfunction, impaired ovulation and fertilization, ovarian damage, reduced ovarian reserve, altered oocyte quality, and impaired embryo implantation. This review summarizes the clinical features, epidemiology, risk factors, pathogenesis, diagnostic methods, and therapeutic approaches associated with endometriosis-related infertility. Conventional management includes pain management, hormonal therapy, conservative surgery, lifestyle modification, and assisted reproductive technologies such as intrauterine insemination and in vitro fertilization. Combined ethinyl estradiol and levonorgestrel suppress ovulation and reduce estrogenic stimulation of endometriotic lesions, contributing to control of pain and menstrual symptoms. Linzagolix is an orally administered, non-peptide GnRH receptor antagonist that produces rapid and dose-dependent suppression of ovarian estrogen production. Clinical evidence described in the source document indicates reductions in dysmenorrhea, non-menstrual pelvic pain, and heavy menstrual bleeding, while add-back therapy may reduce hypoestrogenic effects during extended treatment. Management of endometriosis-associated infertility requires a patient-centered approach considering age, disease severity, ovarian function, and reproductive goals.
Full text 1,892 characters · extracted from oa-doi-fallback · click to expand
Therapeutic Advances in Endometriosis-Associated Infertility: From Conventional Hormonal Therapy To Linzagolix DOI: https://doi.org/10.67440/ahj.vi.2874Keywords: Endometriosis; Infertility; Endometriosis-associated infertility; Linzagolix; Ethinyl Estradiol + Levonorgestrel.Abstract Endometriosis is a chronic estrogen-dependent disorder characterized by endometrial-like tissue outside the uterine cavity and is strongly associated with pelvic pain, inflammation, adhesions, and impaired fertility. Endometriosis-associated infertility is multifactorial and may involve pelvic anatomical distortion, tubal dysfunction, impaired ovulation and fertilization, ovarian damage, reduced ovarian reserve, altered oocyte quality, and impaired embryo implantation. This review summarizes the clinical features, epidemiology, risk factors, pathogenesis, diagnostic methods, and therapeutic approaches associated with endometriosis-related infertility. Conventional management includes pain management, hormonal therapy, conservative surgery, lifestyle modification, and assisted reproductive technologies such as intrauterine insemination and in vitro fertilization. Combined ethinyl estradiol and levonorgestrel suppress ovulation and reduce estrogenic stimulation of endometriotic lesions, contributing to control of pain and menstrual symptoms. Linzagolix is an orally administered, non-peptide GnRH receptor antagonist that produces rapid and dose-dependent suppression of ovarian estrogen production. Clinical evidence described in the source document indicates reductions in dysmenorrhea, non-menstrual pelvic pain, and heavy menstrual bleeding, while add-back therapy may reduce hypoestrogenic effects during extended treatment. Management of endometriosis-associated infertility requires a patient-centered approach considering age, disease severity, ovarian function, and reproductive goals.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (21)

Source provenance

openalex
last seen: 2026-11-21T06:07:56.064915+00:00
License: CC0 · commercial use OK